Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?

Bell, 2020, Strategies to promote access to medications during the COVID-19 pandemic, Austr J Gen Pract, 49, 530, 10.31128/AJGP-04-20-5390 Saul, 2020, Victoria's response to a resurgence of COVID-19 has averted 9,000-37,000 cases in July 2020, Med J Aust Chew, 2016, National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016, Heart Lung Circ, 25, 895, 10.1016/j.hlc.2016.06.789 Gumuser, 2021, Trends in cholesterol testing during the COVID-19 pandemic: COVID-19 and cholesterol testing, Am J Prev Cardiol, 6, 10.1016/j.ajpc.2021.100152 Santos, 2022, Impact Of The COVID-19 pandemic on hospital admissions and in-hospital lethality from cardiovascular diseases in Brazil: an ecological and time series study, Curr Probl Cardiol, 10.1016/j.cpcardiol.2022.101216 2021 Storen, 2020 Talic, 2021, Trends in the utilization of lipid-lowering medications in Australia: an analysis of national pharmacy claims data, Curr Probl Cardiol Bytyci, 2022, Prevalence of statin intolerance: a meta-analysis, Eur Heart J, 43, 3213, 10.1093/eurheartj/ehac015 Victoria State Government. Statement from the Premier 26 October 2020. 2020. 2020 Ofori-Asenso, 2018, Prevalence and incidence of statin use and 3-year adherence and discontinuation rates among older adults with dementia, Am J Alzheimers Dis Other Demen, 33, 527, 10.1177/1533317518787314 Ofori-Asenso, 2018, Patterns of statin use and long-term adherence and persistence among older adults with diabetes, J Diabetes, 10, 699, 10.1111/1753-0407.12769 Taylor, 2021, How Australian health care services adapted to telehealth during the COVID-19 pandemic: a survey of telehealth professionals, Front Public Health, 9, 10.3389/fpubh.2021.648009 Rodriguez, 2019, Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease, JAMA Cardiol, 4, 206, 10.1001/jamacardio.2018.4936 Hunt G. Ensuring Continued Access to Medicines During the COVID-19 Pandemic - 31 March 2020. In: Care DoHaA, editor. Canberra, Australia: Australian Government; 2020. Mellish, 2015, The Australian pharmaceutical benefits scheme data collection: a practical guide for researchers, BMC Res Notes, 8, 634, 10.1186/s13104-015-1616-8 2022 Lesén, 2011, A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project, Pharmacoepidemiol Drug Saf, 20, 1073, 10.1002/pds.2204 Yudi, 2020, Prognostic significance of suboptimal secondary prevention pharmacotherapy after acute coronary syndromes, Int Med J, 51, 366, 10.1111/imj.14750